https://www.news-medical.net/news/2...ls-damaged-by-noise-prevent-hearing-loss.aspx
"Audiologist and molecular biologist O'neil Guthrie, an associate professor in NAU's Department of Communication Sciences and Disorders, is collaborating with New Jersey-based Optigenex on a three-year contract totaling $551,000.
Guthrie will conduct a pre-clinical investigation of a novel therapy using the company's patented ac-11 technology based on carboxy alkyl esters, which help the body's natural ability to repair DNA.
Guthrie believes this therapy, which will be administered as a single oral formulation, has the potential to repair cells damaged by noise and prevent hearing loss. As an added benefit, the technology can also target ROS and inflammation to prevent cell death in the cochlea.
By developing a single drug given orally as a vitamin or gummy that addresses all three problems, Guthrie hopes to make the drug as safe and effective as possible, avoiding unknown or poorly understood interactions between multiple drugs and their side effects."
""The possibility of finally developing a treatment for hearing loss is particularly exciting," Guthrie said. "This is because, in addition to being a research scientist, I am also a licensed clinical audiologist with more than 17 years' experience, so I am familiar with the day-to-day struggles of individuals who suffer with hearing loss."
Another thing that looks promising in the inner ear field.
Member
